Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Four Cycles of Cisplatin-Based Chemotherapy in Metastatic Urothelial Carcinoma Compared to Six Cycles: Randomized Phase III Trial - FOCUS Study -

NCT03296306 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT03296306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Four Cycles of Cisplatin-Based Chemotherapy in Metastatic Urothelial Carcinoma Compared to Six Cycles: Randomized Phase III Trial - FOCUS Study -
Lead sponsor
Asan Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2016
Completion date
February 28, 2022
Enrollment
330 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, transitional cell carcinoma, ureter cancer, urethral cancer